Announced Tue, 7 Jul · 10:27 IST

Routine compliance certificate from registrar for Q1 FY27

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-4.9%1-day move

₹1399.80

prior close

—

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————-4.9+3.6+2.9+1.1+1.3-4.9+8.1———

Up moveDown movePending

AI summary

Bharat Parenterals has submitted a routine compliance certificate under SEBI regulation 74(5) for the quarter ended June 30, 2026. The certificate, issued by the company's registrar Adroit Corporate Services, confirms that share certificates received for demat (dematerialisation) during the quarter were properly processed, the physical certificates were destroyed, and the depository name was updated in the company's register of members within 15 days. This is a standard procedural filing required every quarter and carries no business or financial information.

Likely market impact

No impact on shareholders or stock price. This is a routine quarterly procedural filing with no business or financial information.